List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 407 studies with search of: Attention Deficit/Hyperactivity Disorder (ADHD)
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Dietary Supplement: Zinc, Magnesium, Vitamin B6, Vitamin C (Compound Natural Health Product for ADHD)
2 Recruiting A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Interventions: Drug: JNJ-31001074 1 mg/d;   Drug: JNJ-31001074 10 mg/d;   Drug: Atomoxetine 80 mg/d;   Drug: OROS methylphenidate HCl 54 mg/d;   Drug: JNJ-31001074 3 mg/d;   Drug: Placebo
3 Recruiting Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
Conditions: Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention: Drug: Atomoxetine
4 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
5 Recruiting New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
6 Recruiting A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine hydrochloride;   Drug: placebo
7 Recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
8 Recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
9 Recruiting Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine
10 Not yet recruiting Pilot Study of Duloxetine in Adult ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: duloxetine;   Drug: placebo
11 Completed A Multicenter Open Trial to Evaluate the Effectiveness and Quality of Life in Adults With Attention Deficit /Hyperactivity Disorder (ADHD) Treated With Long Acting Methylphenidate
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
12 Completed
Has Results 		An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
13 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
14 Recruiting Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit/Hyperactivity Disorder;   Smoking Cessation
Intervention: Drug: Varenicline (Chantix)
15 Completed A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention-Deficit/Hyperactivity Disorder;   ADHD
Interventions: Drug: ABT-894;   Drug: atomoxetine;   Drug: placebo
16 Completed A Study Comparing the Effect of Atomoxetine vs Other Standard Care Therapy on the Long Term Functioning in ADHD Children and Adolescents
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine;   Drug: Other standard therapy for ADHD
17 Not yet recruiting Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
Condition: Attention-Deficit/Hyperactivity Disorder
Interventions: Drug: extended-release guanfacine hydrochloride;   Drug: placebo
18 Recruiting An In Depth Cardiovascular Study of Lisdexamfetamine (LDX; Vyvanse) in Healthy and Treated Hypertensive Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit/Hyperactivity Disorder(ADHD)
Intervention: Drug: Lisdexamfetamine (LDX; Vyvanse)
19 Completed Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
Condition: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Drug: Dex-Methylphenidate Extended Release;   Drug: Placebo
20 Recruiting Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
Condition: Attention-Deficit/Hyperactivity Disorder (ADHD)
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services